SCHEMBL7093407

SCHEMBL7093407

Cc1cccc(-c2cnc(N)nc2-c2c[nH]c(C(=O)N3CCC(O)CC3)c2)c1.Nc1ncc(-c2ccccc2)c(-c2c[nH]c(C(=O)N3CCN(c4ccccc4F)CC3)c2)n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.45
ALDH1A1 P00352 3/20 0.44
HTT P42858 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
CCKAR P32238 5/20 0.39
MAPK1 P28482 2/20 0.39
USP2 O75604 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 1/20 0.38
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
HSD17B10 Q99714 1/20 0.37
MT-CO1 P00395 2/20 0.37
CNR2 P34972 2/20 0.37
PANK3 Q9H999 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5407239 0.94 ALDH1A1 (0.49) ADORA1ALDH1A1HTTL3MBTL1SMN1; SMN2
SCHEMBL5415850 0.89 ALDH1A1 (0.49) ADORA1ALDH1A1HTTL3MBTL1SMN1; SMN2
SCHEMBL5403894 0.89 ADORA1 (0.52) ADORA1CCKARMAPK1ALOX5APFEN1
SCHEMBL5407293 0.85 MEN1 (0.49) ADORA1ALDH1A1HTTL3MBTL1SMN1; SMN2
SCHEMBL5412680 0.85 ADORA1 (0.54) ADORA1KMT2ACCKAR
SCHEMBL5396033 0.84 ADORA1 (0.46) ADORA1KMT2AMAPK1NPSR1LMNA
SCHEMBL5405217 0.81 ADORA1 (0.50) ADORA1ALDH1A1HTTL3MBTL1SMN1; SMN2
SCHEMBL5397011 0.81 ADORA1 (0.53) ADORA1CCKARMAPK1
SCHEMBL5407288 0.81 MEN1 (0.53) ALDH1A1HTTL3MBTL1SMN1; SMN2MEN1
SCHEMBL5412664 0.80 ADORA1 (0.48) ADORA1MAPK1ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363906-A2 HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-11-26 EP claimed
WO-2002064586-A2 HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-08-22 WO claimed